EVALUATION OF HORIZONTAL RIDGE AUGMENTATION USING BETA TRICALCIUM PHOSPHATE AND DEMINERALIZED BONE MATRIX: A COMPARATIVE STUDY

The use of equine enzymatically deantigenated demineralized bone matrix in combination with a synthetic graft in alveolar ridge augmentation

The aim of the study is to evaluate the effectiveness of beta tricalcium phosphate (beta-TCP) alone compared to beta-TCP and Demineralized Bone Matrix (DBM) in regenerating localized horizontal maxillary alveolar ridge deficiencies prior to implant placement. The study included 20 patients with horizontal maxillary ridge deficiencies limited to one or more neighbouring teeth and initial ridge width of </= 5mm. Within the limitations of this study the combination of DBM and beta-TCP can be used effectively in cases exhibiting minimal alveolar ridge defects. 

PRODUCTS USED: Osteoplant Activagen